02:07 PM, 21st Feb 2025
Pursuant to the Regulation 30 of the Listing Regulations we hereby inform that the Board of Directors of the Company at their Meeting held today that commenced on February 20 2025 at 11.00 a.m. and concluded on February 21 2025 at 1.45 p.m have approved a proposal today to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company viz. Ativan and Pacitane.